1 suspended. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Suspended 1 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide to Reduce Atrial Fibrillation Burden Semaglutide, Placebo - Atrial Fibrillation, Obesity | Phase 4 | Suspended | San Francisco Veterans Affairs Medical Center | 132 | 2023-05-01 | 2022-10-27 |
Atrial Fibrillation (1) · Obesity (1) · Weight Loss (1)
Arrhythmias, Cardiac (1) · Body Weight (1) · Body Weight Changes (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
semaglutide (1)
San Francisco Veterans Affairs Medical Center (1)
United States (1)